URGN vs MSFT: Which Stock is Better?
Side-by-side comparison of UroGen Pharma Ltd and Microsoft Corporation in 2026
URGN
UroGen Pharma Ltd
$44.42
MSFT
Microsoft Corporation
$495.83
Key Metrics Comparison
| Metric | URGN | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.61B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | URGN |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | -2.5% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze URGN
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is URGN or MSFT a better investment?
Comparing URGN and MSFT: UroGen Pharma Ltd has a market cap of $1.61B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between URGN and MSFT?
URGN (UroGen Pharma Ltd) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: URGN or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: URGN or MSFT?
MSFT has higher revenue growth at 18.4% vs -2.5% for URGN.
Which company is more profitable: URGN or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for URGN.
Which is the larger company: URGN or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.61B for URGN.
Should I buy URGN or MSFT in 2026?
Both URGN and MSFT have investment merit. URGN trades at $44.42 while MSFT trades at $495.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between URGN and MSFT stock?
Key differences: Market Cap ($1.61B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (-2.5% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy URGN or MSFT in 2026?
The choice between URGN and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between URGN and MSFT?
URGN (UroGen Pharma Ltd) has a market cap of $1.61B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.